This page houses the traditional and general business plan document for Innovative Potential.

 

Innovative Potential Inc. was first structured and created in 2016 as a mechanism for cost-effectively creating the documents required for participation in financial, government grant, and business startup monetary programs. Only two (2) initial customers were serviced by Innovative Potential: myself in creating and purchasing the CGP and its patents, and someone else: they received a grant prize of over $15,000 from the documents that Innovative Potential created.

 

The Business Plan is being updated as needed.

​

- - - 

​​​

You will need to understand and accept the following three (3) operational contexts before proceeding to The Business Plan:
 

1. Legally: Innovative Potential behaves closest to an international treaty or independent state corporation regarding: electrochemically activated chemotherapy (EAC), intratumor injection (ITI), the chemotherapeutic galvanostat/potentiostat (CGP), and or any derivative process(es) and product(s) therein. Public rights regarding EAC, ITI, the CGP and or any other ancillary product(s) or process(es) therein, are already regulated through either the Canadian, the United States, and or an other internationally recognized regulating body (e.g., The European Union); and,
    

2. Internet: Innovative Potential is a biomedical first-principles entity. Innovative Potential exists unilaterally and ubiquitiously everywhere first-and-foremost with respect to the chemotherapeutic galvanostat/potentiostat via the supporting mechanisms and patents found in (1); and,
    

3. Financially: Because of the plethora of planetary-firsts derived from Innovative Potential and its technologies: it is fundamentally incorrect to apply or use a revenue-based business model to Innovative Potential: Innovative Potential is a top-down value-model asset-based entity. Innovative Potential makes concepts and technologies real, then considers run-of-the-mill trade (i.e., revenue). Innovative Potential scales in-favor of Jordache Boudreau, and itself, instantaneously World-wide for everything that it does, and that is value-add globalized economics, not supply-and-demand revenue-based trade. You're running your Chattel Empire wrong, again, and it shows.
   ​

Additionally, Innovative Potential is:
 

• An internationally recognized and entreatied company via the Patent Cooperation Treaty; and,
   

• A federally-recognized and legal monopoly of Canada and the United States of America; and,
   

• Granted patented and exclusivized market powers from: 2017-2038, in both Canada and the United States of America; and,
   

• Internationally cross-licensed through a set of exclusive licensing agreements for the sharing and proliferation of intellectual property, including patents; and,
   

• The Problem is actually and legally: You.